Skip to main content

Table 2 Risk stratification according to the patients’ characteristics

From: SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media

Group

Risk factors

Level of risk

Allergy evaluation for CM

0

Female gender [19]

Atopy [19]

Intravascular CM injection [23]

Severe cardiovascular disease [23]

Viral infection and autoimmune diseases [1]

Psychiatric disorders [23]

Interleukin-2 treatment and contact allergy (for NIHRs) [2]

Treatment with ACE-inhibitors, beta-blockers, or proton pump inhibitors (for IHRS) [19]

Food allergy [23]

Drug allergy [24]

Concomitant allergic disease [23]

Allergy to iodine-containing antiseptics [25]

Very low (not relevant)

No

1

Uncontrolled asthma [21, 22]

Active urticaria-angioedema [2, 22]

Mastocytosis [19]

Recurrent angioedema

Idiopathic anaphylaxis

Medium

No

2

History of hypersensitivity reactions to contrast media of the same class of the one to be administered [1, 7, 17, 18, 20]

High

Yes